Diabetic Peripheral Neuropathy (DPN) Completed Phase 3 Trials for Capsaicin (DB06774)

Also known as: Peripheral Diabetic Neuropathy / Diabetic Peripheral Neuropathy / Diabetic Neuropathy Peripheral / Diabetic neuropathy / Diabetic Neuropathies

IndicationStatusPhase
DBCOND0049986 (Diabetic Peripheral Neuropathy (DPN))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT031134480.075% Capsaicin Lotion for the Treatment of Painful Diabetic NeuropathyTreatment
NCT01533428A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)Treatment